Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SSTR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC101927137 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYNJ2BP-COX16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD13C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCOR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHIC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERBIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DOCK5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPD52 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL6A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DEFB119 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on